Background: Pediatric epileptic encephalopathies comprises a group of severe childhood epilepsy syndromes characterized by refractory seizures associated with progressive cerebral dysfunction, manifesting as cognitive or learning difficulties and behavioural or sensory impairments.Objectives: To describe the clinical and electroencephagraphic profile of children seen with epileptic encephalopathy in Sokoto, Northwestern Nigeria.Methodology: This is a descriptive report of cases of epileptic encephalopathy seen in a Pediatric Neurology Clinic, over a 5-year period (Jan. 2015 to Dec. 2020).Results: Twenty-one cases that satisfied the definition criteria for childhood epileptic encephalopathy where identified over the study period, out of a total number 413 children diagnosed with epilepsy over the period, giving a hospital prevalence of 5.1%. Three of the cases were excluded due to incomplete data. Four (4) different syndromes of EE were recorded, namely: Epileptic spasms/West syndrome, Lennox-Gastaut syndrome, Doose syndrome and Landau-Kleffner syndrome. Epileptic spasm was the most prevalent type recorded in 7 (38.9%) cases, followed by Lennox-Gastaut syndrome in 6 (33.3%), Landau-Kleffner syndrome in 3 (16.7%) and Doose Syndrome in 2 (11.1%) in that order.The mean age at diagnosis was 17.00 ± 6.50 months, with a male to female ratio of 1.6:1. There was a significant association between age of seizure onset and the type of seizure syndrome.
Conclusion:Pediatric epileptic encephalopathies are prevalent in our society, with epileptic spasms/West syndrome and Lennox-Gastaut syndromes leading the list. Perinatal asphyxia was the main risk factor identified among the cases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.